These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2414358)

  • 1. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.
    Novick DM; Lok AS; Thomas HC
    J Hepatol; 1985; 1(1):29-35. PubMed ID: 2414358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
    Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
    Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
    Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC
    J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
    Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
    Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
    Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
    Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
    McDonald JA; Caruso L; Karayiannis P; Scully LJ; Harris JR; Forster GE; Thomas HC
    Hepatology; 1987; 7(4):719-23. PubMed ID: 3038722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
    Hoofnagle JH
    J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM
    J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
    Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
    Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B surface antigen (HBsAg) and antibody to HBsAg. Prevalence in homosexual and heterosexual men.
    Dietzman DE; Harnisch JP; Ray CG; Alexander ER; Holmes KK
    JAMA; 1977 Dec; 238(24):2625-6. PubMed ID: 579199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
    Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
    JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of hepatitis B virus (HBV) markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infection.
    Mora I; Porres JC; Bartolomé J; Quiroga JA; Gutiez J; Hernández Guio C; Bas C; Carreño V
    J Hepatol; 1987 Feb; 4(1):29-36. PubMed ID: 3571931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
    Scullard GH; Pollard RB; Smith JL; Sacks SL; Gregory PB; Robinson WS; Merigan TC
    J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver disease among homosexual males.
    Ellis WR; Murray-Lyon IM; Coleman JC; Evans BA; Fluker JL; Bull J; Keeling PW; Simmons PD; Banatvala JE; Willcox JR; Thompson RP
    Lancet; 1979 Apr; 1(8122):903-5. PubMed ID: 86669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
    Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological improvement after anti-viral treatment for chronic hepatitis B virus infection.
    Brook MG; Petrovic L; McDonald JA; Scheuer PJ; Thomas HC
    J Hepatol; 1989 Mar; 8(2):218-25. PubMed ID: 2469711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.